Editor’s Note
**Editor’s Note:** This article highlights a strategic investment aimed at deepening collaboration between two firms, with a focus on joint development and commercialization of skin boosters and medical devices. The move signals a commitment to long-term innovation and partnership in the medical aesthetics sector.
Amorepacific Holdings has made a strategic investment in Higher Corporation, a specialized aesthetic medical device company, and will collaborate in the beauty and medical fields.
Amorepacific Holdings announced on the 27th that it has signed an investment agreement with Higher Corporation to strengthen cooperation in the beauty and medical sectors. The two companies plan to combine Higher Corporation’s aesthetic medical device development capabilities, joint medical research, and global Key Opinion Leader (KOL) network with Amorepacific’s skin science research and skincare technology.
In particular, the two companies will focus on developing integrated beauty solutions that connect professional treatment areas with daily skincare. Lee Sang-mok, CEO of Amorepacific Holdings, stated:
Kim In-yong, CEO of Higher Corporation, commented:
Based on this partnership, the companies will collaborate across product planning, R&D, distribution, and marketing. Key areas of cooperation include the development and commercialization of skin boosters, cosmeceuticals, and medical devices for skin aesthetics. They will also jointly develop post-procedure aftercare products, distribute through hospitals and clinics, and conduct joint research on raw materials and ingredients, as well as marketing activities.
Meanwhile, CEO Lee is scheduled to attend the ‘Korea-Brazil Business Roundtable’ in São Paulo on the 28th (local time) during President Lee Jae-myung’s visit to Brazil.